Alutard SQ grass demonstrates clinical efficacy in subjects with seasonal allergic rhinoconjunctivitis in a large-scale double-blind placebo controlled study of specific allergy vaccination (the AVANZ study)*1

2004 ◽  
Vol 113 (2) ◽  
pp. S105
Author(s):  
A FREW
Keyword(s):  
Clinical Efficacy ◽  
Large Scale ◽  
Allergic Rhinoconjunctivitis ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: Clinical efficacy and safety

2007 ◽  
Vol 0 (0) ◽  
pp. 070725210739001-??? ◽  
Author(s):  
Ana I. Tabar ◽  
María T. Lizaso ◽  
Blanca E. García ◽  
Belen Gómez ◽  
Susana Echechipía ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Alternaria Alternata ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Clinical Evaluation of Ramosetron Injections in the Treatment of Cisplatin-Induced Nausea and Vomiting

2002 ◽  
Vol 30 (3) ◽  
pp. 211-219 ◽  
Author(s):  
K Noda ◽  
M Ikeda ◽  
O Yoshida ◽  
S Yano ◽  
T Taguchi ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Clinical Efficacy ◽  
Clinical Evaluation ◽  
Adverse Reactions ◽  
Phase Iii ◽  
Controlled Study ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Efficacy Analysis

A phase III, double-blind, placebo-controlled study was performed to examine the safety and efficacy of ramosetron in cancer patients with cisplatin-induced nausea/vomiting. Patients were divided into two groups: group R received 0.3 mg ramosetron intravenously and group P received placebo. Eighty-eight patients were enrolled, 44 in each group; 84 (43 in group R, 41 in group P) were included in the clinical efficacy analysis and 86 (44 in group R, 42 in group P) in the safety analysis. Ramosetron was significantly more clinically effective than placebo against nausea, vomiting and anorexia; 65.1% of patients in group R experienced no vomiting in the first 6 h of observation compared with 7.3% of those receiving placebo. No serious adverse reactions or significant differences in safety were observed between the groups. Based on these results, ramosetron injection is effective in the treatment of cisplatin-induced nausea/vomiting and its clinical usefulness is demonstrated here.

Clinical efficacy of hydralazine in chronic heart failure: One-year double-blind placebo-controlled study

1984 ◽  
Vol 108 (4) ◽  
pp. 1001-1006 ◽  
Author(s):  
Thor-Björn Conradson ◽  
Lars Rydén ◽  
Gösta Ahlmark ◽  
Helge Saetre ◽  
Stig Persson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Clinical Efficacy ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document